We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00631072
Recruitment Status : Completed
First Posted : March 7, 2008
Last Update Posted : June 9, 2017
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Steven Balk, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : August 2014
  Study Completion Date : April 2015